INSIGHTS ON DRUG DEVELOPMENT
-
High Potency APIs And The Evolving Demands Of Drug Development
See how higher API activity is changing expectations around containment, scalability, and cross‑functional alignment — and why early decisions now have a greater impact on long‑term success.
-
Particles In High Concentration Biotherapeutics
Examine advanced analytical solutions that detect, characterize, and mitigate particle formation in high-concentration biotherapeutics caused by protein aggregation and surfactant degradation.
-
What Is DMPK, And Why Does It Matter In Drug Development?
By leveraging advanced DMPK software solutions, you can streamline your workflows and make informed decisions with confidence.
-
Enhancing Throughput And Reproducibility In Proteomic Analysis
Streamline proteomic workflows with consistent sample preparation. Discover how simplifying LC-MS processes can eliminate bottlenecks, improve reproducibility, and accelerate drug discovery research.
-
A Sensory Panel Study With The Focus On High-Intensity Sweeteners8/5/2026
Gain insight into the sensory performance of five high-intensity sweeteners in a simulated bitter formulation, including their effects on sweetness, bitterness, aftertaste, and covering ability.
-
KORSCH Virtual Pharma Expo September 2025: Oral Solid Dose Manufacturing And Packaging9/18/2025
Simulate high-speed tablet production early in development with minimal material. Gain accurate scale-up, faster material characterization, and flexible formulation options—all with one compaction simulator.
-
Ask Us Anything: Michael Tracey On DoE In Process Characterization7/24/2026
Insights into the validation expertise behind process characterization and how deep problem-solving can turn a process into one robust enough to carry a drug to market.
-
The Continuing Challenge Of Drug-Induced Liver Injury9/24/2026
Recent liver safety concerns highlight the limits of conventional preclinical testing. Human-relevant models could help researchers detect drug-induced liver injury earlier and reduce costly setbacks.
-
An Alternative Method Of Drug-Excipient Characterization12/30/2024
Isothermal microcalorimetry (IMC) rapidly screens API-excipient compatibility, detecting physical and chemical interactions faster than conventional methods, saving time and effort in pharmaceutical formulation development.
DRUG DEVELOPMENT SOLUTIONS
-
See how controlled manufacturing, traceability, scalable capacity, and built-in quality checks can reduce risk and support reliable assay workflows, as well as what to look for in a raw material partner.
-
Successful development relies on a deep understanding of a molecule’s unique characteristics. We have the knowledge and expertise to realize the true potential of your molecule, regardless of its complexity.
-
Access the future of AI microscopy
Subjectivity of analysis and poor reproducibility are key hurdles to be overcome for biological image analysis. Standard segmentation can lead to sub-standard results and require substantial manual curation which is subject to human error.
-
Our collaborative approach, proven track record, and deep technical expertise enable us to efficiently advance promising candidates, reduce development risk, and help transform innovative ideas into successful therapeutic realities.
-
S APO Greenough Stereo Microscope
Save up to 20% inspection and rework time*
Continuously improving production, keeping defect rates low, and fulfilling customer requests in order to stay competitive can be very challenging. Leica has developed the S9 stereo microscope series to help you cope with these challenges. With this generation of Greenough stereo microscopes operators will be able to reveal details faster as they spend less time having to adjust the microscope.
*compared to the standard industrial stereo microscope S6 from Leica